OCRIPLASMIN APPROVED TO TREAT VITREORETINAL ADHESION
This report in Reuters announces the approval of Ocriplasmin,
"for treatment of symptomatic vitreomacular adhesion - an aging-related pulling on the retina"
Comments
Post a Comment
Leave a Comment or Question: